跳至主要内容
临床试验/NCT03974074
NCT03974074Unknown3 期

Albumin Infusion for Patients With Hepatocellular Carcinoma and Hypoproteinemia After Hepatectomy

Guangxi Medical University2 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2019年3月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
发起方
入组人数
200
试验地点
2
主要终点
Serum albumin level

研究概览

简要总结

The rate of liver cirrhosis is about 40% to 75% among patients with hepatocellular carcinoma (HCC). Therefore, many patients with HCC were with low serum albumin before and after (especially) hepatic resection. Serum albumin level has been routinely used in clinical practice as a surrogate marker to evaluate nutritional status and liver function. Serum albumin concentration is used as an independent mortality risk predictor in a broad range of clinical and research settings. However, the role of albumin infusion in patients with hepatocellular carcinoma (HCC) after resection is unknown. The present study aimed to investigate the safety and clinical necessity of albumin infusion for HCC patients after hepatic resection.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Body mass index >18.5;
  • Patients with primary hepatocellular carcinoma without any treatments for tumors before resection;
  • Hepatocellular carcinoma should be confirmed by histopathology;
  • With preserved liver function (Child-Pugh score ≤7) before resection
  • ECOG performance score 0 or 1;
  • Preoperative serum albumin >35g/L;
  • The level of postoperative serum albumin is between 25-30g/L in the first day after resection.

排除标准

  • Patients used albumin before liver resection (<1 months);
  • Plasma was used during or after liver resection;
  • Surgery involving the extrahepatic bile duct or gastrointestinal tract.

研究组 & 干预措施

Albumin infusion group

Experimental

Albumin infusion (20 g, ivgtt, qd) will be performed to patients with HCC after hepatic resection in 24 h for three days. All patients wil receive furosemide (10 mg, iv) after albumin transfusion. In the fifth day after resection, patients will receive albumin transfusion if they have ascites with shifting dullness, moderate edema (below both lower ankle joints) with serum albumin lower than 30 g/L, severe postoperation complication (septicopyemia, postoperative bleeding with reoperation, or biliary fistula).

干预措施: Albumin infusion (Drug)

结局指标

主要结局

Serum albumin level

时间窗: Change from Baseline serum albumin at the fifth and seventh days after resection

Recovery of liver function between the two groups

Serum total bilirubin level

时间窗: Change from Baseline total bilirubin at the fifth and seventh days after resection

Recovery of liver function between the two groups

次要结局

  • Rate of postoperative complications(The first months after resection)
  • Abdominal girth(Change from Baseline abdominal girth at the fifth and seventh days after resection)

研究者

发起方
Guangxi Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Jian-Hong Zhong

Principal Investigator

Guangxi Medical University

研究点 (2)

Loading locations...

相似试验